INKT logo

MiNK Therapeutics, Inc. (INKT)

Profile

Full Name

MiNK Therapeutics, Inc.

Ticker

NASDAQ: INKT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 15, 2021

Indexes

Not included

Website

http://minktherapeutics.com

Employees

23

Key Details

Price

$64.17(+730.14%)

Market cap

$255.76M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.86(+56.27% YoY)

PE ratio

-

Next earnings date

Aug 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $64.17
    INKT price is $64.17

    30-Day Relative Volume

    29.80
    INKT 30-day relative volume is 29.80

    Price Performance

    Price Most recent change

    +730.14%
    INKT price was up +730.14% on Jul 11, 2025

    Price YTD change

    +820.66%
    INKT price is up +820.66% since January 1st

    Price 1-year change

    +562.23%
    INKT price is up +562.23% year-on-year

    Price 3-year change

    +421.71%
    INKT price is up +421.71% over the past 3 years

    Price Range

    Price All-time high

    $221.55
    INKT price is currently -71.04% below its historical high of $221.55

    Price 3-year low

    $4.56
    INKT price is currently +1307.24% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $255.76M
    INKT market capitalization is $255.76 million

    Market cap 3-year change

    +517.57%
    INKT market capitalization is up +517.57% over the past 3 years

    Market cap All-time high

    $670.42M
    INKT market capitalization is currently -61.85% below its historical high of $670.42 million

    Market cap sector rank

    55.95%
    INKT market capitalization is higher than 55.95% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.04%
    INKT shares outstanding is up +1.04% year-on-year

    Shares Outstanding 3-Year Change

    +18.38%
    INKT shares outstanding is up +18.38% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -0.28
    INKT beta is -0.28

    200-day SMA

    $7.98
    INKT price is currently +704.02% above its 200-day simple moving average

    50-day SMA

    $8.46
    INKT price is currently +658.48% above its 50-day simple moving average

    RSI

    98.11
    INKT 14-day relative strength index is 98.11

    Volume

    29.80
    INKT 30-day relative volume is 29.80

    ATR

    $8.94
    INKT average true range is $8.94

    10-day Historical Volatility

    3663.36%
    INKT 10-day historical volatility is 3663.36%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    INKT annual revenue value is unknown

    Revenue Analysts estimate

    -
    INKT annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    INKT annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    INKT annual revenue is unknown

    EPS

    EPS

    -$2.86
    INKT annual earnings per share is -$2.86

    EPS Analysts estimate

    -$1.98
    INKT annual earnings per share is currently +44.81% higher than the consensus analysts' forecast

    EPS 1-year change

    +56.27%
    INKT annual earnings per share is up +56.27% year-on-year

    EPS Sector rank

    31.53%
    INKT annual earnings per share is higher than 31.53% of companies in Healthcare sector

    Profit

    Gross profit

    -
    INKT annual gross profit value is unknown

    Gross margin

    -
    INKT annual gross profit margin value is unknown

    Operating profit

    -$10.65M
    INKT annual operating income is -$10.65 million

    Operating margin

    -
    INKT annual operating profit margin value is unknown

    Net income

    -$10.78M
    INKT annual net profit is -$10.78 million

    Net margin

    -
    INKT annual net profit margin value is unknown

    Expenses

    Total expenses

    $10.65M
    INKT annual total expenses is $10.65 million

    Operating expenses

    $10.65M
    INKT annual total operating expenses is $10.65 million

    Cost of goods sold

    -
    INKT annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $4.31M
    INKT annual SGA is $4.31 million

    Depreciation and amortization

    $215.40K
    INKT annual depreciation & amortization is $215.40 thousand

    Interest expense

    -
    INKT annual interest expense value is unknown

    Income tax

    -
    INKT annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$10.65M
    INKT annual earnings before interest & taxes is -$10.65 million

    EBITDA

    -$10.43M
    INKT annual EBITDA is -$10.43 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $5.72M
    INKT annual total assets is $5.72 million

    Non current assets

    $732.90K
    INKT annual long term assets is $732.90 thousand

    Current assets

    $4.99M
    INKT annual total current assets is $4.99 million

    Cash and cash equivalents

    $4.58M
    INKT annual cash & cash equivalents is $4.58 million

    Accounts receivable

    -
    INKT annual accounts receivable value is unknown

    Inventory

    -
    INKT annual inventory value is unknown

    Liabilities

    Total liabilities

    $25.31M
    INKT annual total liabilities is $25.31 million

    Long term liabilities

    $18.35M
    INKT annual total long term liabilities is $18.35 million

    Current liabilities

    $6.96M
    INKT annual total current liabilities is $6.96 million

    Accounts payable

    $2.73M
    INKT annual accounts payable is $2.73 million

    Debt

    Total debt

    $4.92M
    INKT annual total debt is $4.92 million

    Total debt 1-year change

    +100%
    INKT annual total debt is up +100% year-on-year

    Long term debt

    $4.92M
    INKT annual long term debt is $4.92 million

    Short term debt

    -
    INKT annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    -$19.59M
    INKT annual stockholders equity is -$19.59 million

    Book value

    -$19.59M
    INKT annual book value is -$19.59 million

    Retained earnings

    -$144.18M
    INKT annual retained earnings is -$144.18 million

    Working capital

    -$1.97M
    INKT annual working capital is -$1.97 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$9.56M
    INKT annual cash flow from operations is -$9.56 million

    Cash from operations 1-year change

    +39.38%
    INKT annual cash flow from operations is up +39.38% year-on-year

    Cash from investing

    $0.00
    INKT annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    +100%
    INKT annual cash flow from investing activities is up +100% year-on-year

    Cash from financing

    $10.82M
    INKT annual cash flow from financing activities is $10.82 million

    Cash from financing 1-year change

    +2757.17%
    INKT annual cash flow from financing activities is up +2757.17% year-on-year

    CAPEX

    CAPEX

    -
    INKT annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    INKT annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$9.56M
    INKT annual free cash flow is -$9.56 million

    Free cash flow 1-year change

    +39.66%
    INKT annual free cash flow is up +39.66% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    INKT annual gross profit margin value is unknown

    Operating margin

    -
    INKT annual operating profit margin value is unknown

    Net margin

    -
    INKT annual net profit margin value is unknown

    ROA & ROE

    ROA

    -188.52%
    INKT annual return on assets is -188.52%

    ROE

    55.06%
    INKT annual return on equity is 55.06%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    INKT price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    INKT price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -11.74
    INKT price to book ratio is -11.74

    PB ratio Sector rank

    3.47%
    INKT price to book ratio is higher than 3.47% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    INKT price to sales ratio value is unknown

    PS ratio Sector rank

    -
    INKT price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $257.64M
    INKT enterprise value is $257.64 million

    Enterprise value Sector rank

    57%
    INKT enterprise value is higher than 57% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -28.19
    INKT EV/EBITDA is -28.19

    EV/EBITDA Sector rank

    6.07%
    INKT EV/EBITDA is higher than 6.07% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.72
    INKT annual current ratio is 0.72

    Quick ratio

    -
    INKT annual quick ratio value is unknown

    Leverage

    Debt to equity

    -0.25
    INKT annual debt to equity ratio is -0.25

    Interest coverage ratio

    -
    INKT annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    INKT piotroski f-score value is unknown

    Altman Z-Score

    -
    INKT altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Mar 18, 25 HC Wainwright & Co.
    Buy
    Feb 25, 25 HC Wainwright & Co.
    Buy
    Nov 15, 24 HC Wainwright & Co.
    Buy
    Nov 15, 24 Baird
    Outperform
    Oct 9, 24 HC Wainwright & Co.
    Buy
    Aug 13, 24 HC Wainwright & Co.
    Buy
    May 14, 24 HC Wainwright & Co.
    Buy
    Mar 21, 24 HC Wainwright & Co.
    Buy
    Aug 10, 23 HC Wainwright & Co.
    Buy
    May 12, 23 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with INKT included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    Stocks above analysts price target
    Best performing stocks last 3 years
    • What is the ticker symbol for MiNK Therapeutics, Inc.?
    • Does MiNK Therapeutics, Inc. pay dividends?
    • What sector is MiNK Therapeutics, Inc. in?
    • What industry is MiNK Therapeutics, Inc. in?
    • What country is MiNK Therapeutics, Inc. based in?
    • When did MiNK Therapeutics, Inc. go public?
    • Is MiNK Therapeutics, Inc. in the S&P 500?
    • Is MiNK Therapeutics, Inc. in the NASDAQ 100?
    • Is MiNK Therapeutics, Inc. in the Dow Jones?
    • When was MiNK Therapeutics, Inc.'s last earnings report?
    • When does MiNK Therapeutics, Inc. report earnings?

    What is the ticker symbol for MiNK Therapeutics, Inc.?

    The ticker symbol for MiNK Therapeutics, Inc. is NASDAQ:INKT

    Does MiNK Therapeutics, Inc. pay dividends?

    No, MiNK Therapeutics, Inc. does not pay dividends

    What sector is MiNK Therapeutics, Inc. in?

    MiNK Therapeutics, Inc. is in the Healthcare sector

    What industry is MiNK Therapeutics, Inc. in?

    MiNK Therapeutics, Inc. is in the Biotechnology industry

    What country is MiNK Therapeutics, Inc. based in?

    MiNK Therapeutics, Inc. is headquartered in United States

    When did MiNK Therapeutics, Inc. go public?

    MiNK Therapeutics, Inc.'s initial public offering (IPO) was on October 15, 2021

    Is MiNK Therapeutics, Inc. in the S&P 500?

    No, MiNK Therapeutics, Inc. is not included in the S&P 500 index

    Is MiNK Therapeutics, Inc. in the NASDAQ 100?

    No, MiNK Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is MiNK Therapeutics, Inc. in the Dow Jones?

    No, MiNK Therapeutics, Inc. is not included in the Dow Jones index

    When was MiNK Therapeutics, Inc.'s last earnings report?

    MiNK Therapeutics, Inc.'s most recent earnings report was on May 15, 2025

    When does MiNK Therapeutics, Inc. report earnings?

    The next expected earnings date for MiNK Therapeutics, Inc. is August 13, 2025
    On this page